Antibiotic susceptibility pattern of Portuguese environmental Legionella isolates.


Journal

Frontiers in cellular and infection microbiology
ISSN: 2235-2988
Titre abrégé: Front Cell Infect Microbiol
Pays: Switzerland
ID NLM: 101585359

Informations de publication

Date de publication:
2023
Historique:
received: 10 01 2023
accepted: 24 03 2023
medline: 9 5 2023
pubmed: 8 5 2023
entrez: 8 5 2023
Statut: epublish

Résumé

Legionnaires' Disease is a pneumonia caused by Minimal inhibitory concentration (MIC) determination of 57 Fluoroquinolones were the most active antibiotic, displaying the lowest MIC values in contrast to doxycycline which had the highest. MIC90 and epidemiological cut-off (ECOFF) values were, respectively, 0.5/1 mg/L for azithromycin, 0.125/0.25 mg/L for clarithromycin, 0.064/0.125 mg/L for ciprofloxacin, 0.125/0.125 mg/L for levofloxacin and 16/32 mg/L for doxycycline. MIC distributions were higher than reported by EUCAST for all antibiotics. Interestingly, two phenotypically resistant isolates with high-level quinolone resistance were identified. This is the first time that MIC distributions,

Identifiants

pubmed: 37153155
doi: 10.3389/fcimb.2023.1141115
pmc: PMC10160366
doi:

Substances chimiques

Levofloxacin 6GNT3Y5LMF
Azithromycin 83905-01-5
Clarithromycin H1250JIK0A
Doxycycline N12000U13O
Anti-Bacterial Agents 0
Fluoroquinolones 0
Ciprofloxacin 5E8K9I0O4U

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1141115

Commentaires et corrections

Type : ErratumIn

Informations de copyright

Copyright © 2023 Cruz, Rodrigues, Fernandes, Santos, Paixão and Chasqueira.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Environ Sci Technol. 2013 Jan 15;47(2):661-77
pubmed: 23227929
J Environ Sci (China). 2021 Jan;99:21-27
pubmed: 33183698
J Antimicrob Chemother. 2021 Apr 13;76(5):1197-1204
pubmed: 33367732
Antimicrob Agents Chemother. 2017 Feb 23;61(3):
pubmed: 28069647
Environ Int. 2020 Jul;140:105733
pubmed: 32353669
Environ Toxicol Chem. 2016 Nov;35(11):2647-2656
pubmed: 27392330
Sci Total Environ. 2019 May 10;664:793-804
pubmed: 30763859
Antimicrob Agents Chemother. 2017 Jan 24;61(2):
pubmed: 27895010
Int J Antimicrob Agents. 2017 Nov;50(5):684-689
pubmed: 28782709
Front Microbiol. 2022 Aug 18;13:924709
pubmed: 36312931
Nat Rev Microbiol. 2014 Jul;12(7):465-78
pubmed: 24861036
Clin Microbiol Infect. 2006 May;12(5):418-25
pubmed: 16643517
Water Sci Technol. 2019 Feb;79(3):526-536
pubmed: 30924807
Environ Microbiol. 2007 May;9(5):1267-77
pubmed: 17472639
J Antimicrob Chemother. 2009 Aug;64(2):284-93
pubmed: 19474069
Sci Rep. 2016 Sep 16;6:33442
pubmed: 27633769
Microorganisms. 2021 Jan 31;9(2):
pubmed: 33572638
Scand J Infect Dis. 2010;42(2):152-5
pubmed: 19916901
Environ Res. 2018 Jul;164:574-579
pubmed: 29625340
Clin Infect Dis. 2007 Mar 1;44 Suppl 2:S27-72
pubmed: 17278083
J Antimicrob Chemother. 2014 Oct;69(10):2869-71
pubmed: 24898020
Microb Drug Resist. 2020 Aug;26(8):991-996
pubmed: 32125920
Open Forum Infect Dis. 2017 Oct 07;4(4):ofx184
pubmed: 29026871
mBio. 2018 Jul 24;9(4):
pubmed: 30042197
Chem Biol. 2015 Jul 23;22(7):888-97
pubmed: 26097034
J Water Health. 2016 Dec;14(6):1041-1046
pubmed: 27959883
J Antimicrob Chemother. 2017 May 1;72(5):1327-1333
pubmed: 28137939
Int J Environ Res Public Health. 2021 Sep 04;18(17):
pubmed: 34501942
J Antimicrob Chemother. 2019 Jun 1;74(6):1545-1550
pubmed: 30815687
J Antimicrob Chemother. 2018 Oct 1;73(10):2757-2761
pubmed: 30053025
N Engl J Med. 2016 Feb 4;374(5):497-8
pubmed: 26840151
Microbiol Spectr. 2022 Jun 29;10(3):e0114021
pubmed: 35438512
Environ Res. 2018 Oct;166:638-646
pubmed: 29982152
J Antimicrob Chemother. 2021 Apr 13;76(5):1113-1116
pubmed: 33608737
Antimicrob Agents Chemother. 2000 Oct;44(10):2679-83
pubmed: 10991843
Eur Respir J. 2011 Dec;38(6):1250-1
pubmed: 22130759

Auteurs

Carolina Cruz (C)

NOVA Medical School, Faculdade de Ciências Médicas, Universidade NOVA de Lisboa, Lisboa, Portugal.

Lúcia Rodrigues (L)

Comprehensive Health Research Center, NOVA Medical School, Faculdade de Ciências Médicas, Universidade NOVA de Lisboa, Lisboa, Portugal.

Filipa Fernandes (F)

Laboratório de Análises de Água, Técnico Lisboa, Universidade de Lisboa, Lisboa, Portugal.

Ricardo Santos (R)

Laboratório de Análises de Água, Técnico Lisboa, Universidade de Lisboa, Lisboa, Portugal.

Paulo Paixão (P)

Comprehensive Health Research Center, NOVA Medical School, Faculdade de Ciências Médicas, Universidade NOVA de Lisboa, Lisboa, Portugal.

Maria Jesus Chasqueira (MJ)

Comprehensive Health Research Center, NOVA Medical School, Faculdade de Ciências Médicas, Universidade NOVA de Lisboa, Lisboa, Portugal.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH